M&A Deal Summary

Precision BioLogic Acquires Affinity Biologicals

On November 1, 2018, Precision BioLogic acquired medical products company Affinity Biologicals

Acquisition Highlights

This is Precision BioLogic’s 1st transaction in the Medical Products sector.
This is Precision BioLogic’s 1st transaction in Canada.
This is Precision BioLogic’s 1st transaction in Ontario.

M&A Deal Summary
Date	2018-11-01
Target	Affinity Biologicals
Sector	Medical Products
Buyer(s)	Precision BioLogic
Deal Type	Add-on Acquisition

Target

Affinity Biologicals

Ancaster, Ontario, Canada

Affinity Biologicals, Inc. is a manufacturer of 300 reagents and kits used in hemostasis and thrombosis research and diagnostics. Affinity's product line includes an extensive line of coagulation-related antibodies, conjugates, matched-pair antibody sets for immunoassay of human and animal analytes, the VisuLize™ line of complete ELISA kits, and a full line of human plasma products including VisuDep™ Immune-Depleted Factor-Deficient Plasmas, VisuCal™ Calibrator Plasma, and VisuCon™ Control Plasmas.

Search 215,074 Deals Now

SEARCH BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Try Free

Buyer(S) 1

Buyer